Association of the AGT, ACE, NOS3 polymorphism with subclinical arterial wall changes and cardiovascular diseases risk factors

Cover Page

Cite item

Full Text

Abstract

Background. Renin-Angiotensin-Aldosterone System activation (RAAS) and nitric oxide (NO) reduction lead to the changes in the arterial wall, which, in turn, create a favourable environment for the development of cardiovascular diseases (CVD). There is only limited knowledge of the influence of proteins participating in the RAAS activation and providing NO bioavailability on the parameters of the arterial wall state (pulse wave velocity (PWV), carotid artery intima-media thickness (cIMT), endothelium-dependent vasodilation (EDVD), presence of atherosclerotic plaques) and risk factors of CVD.

Aim. Finding the association between the AGT, ACE, NOS3 polymorphism and PWV, cIMT, EDV, presence of atherosclerotic plaques and risk factors of CVD in healthy subjects.

Methods. Using intergroup analysis and models of multiple logistic regression, we examined the association of AGT с.521С>Т polymorphism, AСE Ins>Del polymorphism, NOS3 с.894G>T polymorphism with arterial wall changes and risk factors of CVD in 160 healthy people of different ages.

Results. The CT genotype of AGT с.521С>Т polymorphism was associated with lower levels of systolic blood pressure (BP) (p=0.013) and central systolic BP (p=0.029), higher level of Insulin-Like Growth Factor (IGF) (p=0.027). The DD genotype of ACE Ins>Del polymorphism was associated with a higher waist/hip ratio (p=0.044), lower level of high density lipoprotein cholesterol (p=0.01), lower index of EDVD (p=0.042), higher incidence ofendothelial dysfunction (ED) (p=0.026). The GG genotype of NOS3 с.894G>T polymorphism was associated with higher levels of central systolic BP (p=0.022) and central mean BP (p=0.033), total cholesterol (p=0.025), low density lipoprotein cholesterol (p=0.014) and IGF (p=0.042), higher incidence of ED (p=0.007), albuminuria (p=0.032) and insulin resistance (p=0.03).

Conclusion. We have found the association of the AСE and NOS3 polymorphism with endothelial dysfunction and the metabolic status.

About the authors

A. A. Akopyan

Medical Scientific and Educational Center of Lomonosov Moscow State University; Russian Gerontology Research Center of Pirogov Russian National Research Medical University

Author for correspondence.
Email: a.alexandrova18@gmail.com
ORCID iD: 0000-0002-2362-9798
SPIN-code: 4841-2901

MD, Research intern at the Department of Age-related diseases; Junior Researcher of the Laboratory of Translational medicine

Russian Federation, Moscow

K. I. Kirillova

Medical Scientific and Educational Center of Lomonosov Moscow State University

Email: dkkirillova@gmail.com
ORCID iD: 0000-0002-0873-7387
SPIN-code: 4440-1859
ResearcherId: AAE-4599-2019

MD,Researcher at Medical Laboratory Department

Russian Federation, Moscow

I. D. Strazhesko

Medical Scientific and Educational Center of Lomonosov Moscow State University; Russian Gerontology Research Center of Pirogov Russian National Research Medical University

Email: istrazhesko@gmail.com
SPIN-code: 9049-7884
ResearcherId: AAD-9390-2019

Leading Researcher at the Department of Age-related diseases; MD, PhD, Deputy Director of translational medicine

Russian Federation, Moscow

L. M. Samokhodskaya

Medical Scientific and Educational Center of Lomonosov Moscow State University

Email: SLM@fbm.msu.ru
SPIN-code: 9049-7884

MD,PhD, Associate Professor, Head of Medical Laboratory Department, Medical Scientific and Educational Center 

Russian Federation, Moscow

S. L. Leonov

Polzunov Altai State Technical University

Email: sergey_and_nady@mail.ru

PhD, Professor, Professor at the Department of manufacturing engineering

Russian Federation, Barnaul

E. M. Gelfand

Polzunov Altai State Technical University

Email: gelfand.el@gmail.com
ORCID iD: 0000-0001-5646-9324
SPIN-code: 6624-3640

PhD, Associate Professor, Associate Professor at the Department of higher mathematics

Russian Federation, Barnaul

A. G. Sorokina

Medical Scientific and Educational Center of Lomonosov Moscow State University

Email: drsorokinaag@gmail.com
ORCID iD: 0000-0003-2310-936X
SPIN-code: 2051-0379

MD,Researcher at the Department of Age-related diseases, Medical Scientific and Educational Center 

Russian Federation, Moscow

I. A. Orlova

Medical Scientific and Educational Center of Lomonosov Moscow State University

Email: 5163002@bk.ru
ORCID iD: 0000-0002-8160-5612
SPIN-code: 3153-8373

MD, PhD, Professor, Head of the Department of Age-related diseases, Medical Scientific and Educational Center 

Russian Federation, Moscow

References

  1. World Health Organization. Cardiovascular diseases (heart attack, stroke) [Internet]. WHO; 2019 [accessed 2019 September 26]. Available from: https://www.who.int/westernpacific/health-topics/cardiovascular-diseases.
  2. Стражеско И.Д., Акашева Д.У., Дудинская Е.Н., Ткачева О.Н. Старение сосудов: основные признаки и механизмы // Кардиоваскулярная терапия и профилактика. — 2012. — Т.11. — №4. — С. 93–100. [Strazhesko ID, Akasheva DU, Dudinskaya EN, Tkacheva ON. Vascular ageing: main symptoms and mechanisms. Cardiovascular therapy and prevention. 2012;11(4):93–100. (In Russ).]
  3. Vlachopoulos C, Aznaouridis K, Stefanadis C., Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–1327. doi: 10.1016/j.jacc.2009.10.061.
  4. Mozos I, Malainer C, Horbańczuk J, et al. Inflammatory markers for arterial stiffness in cardiovascular diseases. Front Immunol. 2017;8:1058. doi: 10.3389/fimmu.2017.01058.
  5. Wang WZ. Association between T174M polymorphism in the angiotensinogen gene and risk of coronary artery disease: a meta-analysis. J Geriatr Cardiol. 2013;10(1):59–65. doi: 10.3969/j.issn.1671-5411.2013.01.010.
  6. Luo JQ, Wen JG, Zhou HH, et al. Endothelial nitric oxide synthase gene G894T polymorphism and myocardial infarction: a meta-analysis of 34 studies involving 21,068 subjects. PLoS One. 2014;9(1):e87196. doi: 10.1371/journal.pone.0087196.
  7. Abouelfath R, Habbal R, Laaraj A, et al. ACE insertion/deletion polymorphism is positively associated with resistant hypertension in Morocco. Gene. 2018;658:178–183. doi: 10.1016/j.gene.2018.03.028.
  8. Isordia-Salas I, Santiago-Germán D, Cerda-Mancillas MC, et al. Gene polymorphisms of angiotensin-converting enzyme and angiotensinogen and risk of idiopathic ischemic stroke. Gene. 2019;688:163–170. doi: 10.1016/j.gene.2018.11.080.
  9. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30(10):e47. doi: 10.1093/nar/30.10.e47.
  10. Young CN, Davisson RL. Angiotensin-II, the brain, and hypertension: an update. Hypertension. 2015;66(5):920–926. doi: 10.1161/HYPERTENSIONAHA.115.03624.
  11. Neves MF, Cunha AR, Cunha MR, et al. The role of renin-angiotensin-aldosterone system and its new components in arterial stiffness and vascular aging. High Blood Press Cardiovasc Prev. 2018;25(2):137–145. doi: 10.1007/s40292-018-0252-5.
  12. Strazhesko ID, Tkacheva ON, Akasheva DU, et al. Growth hormone, insulin-like growth factor-1, insulin resistance, and leukocyte telomere length as determinants of arterial aging in subjects free of cardiovascular diseases. Front Genet. 2017;8:198. doi: 10.3389/fgene.2017.00198.
  13. Higashi Y, Sukhanov S, Anwar A, et al. Delafontaine, aging, atherosclerosis, and IGF-1. J Gerontol A Biol Sci Med Sci. 2012;67(6):626–639. doi: 10.1093/gerona/gls102.
  14. González-Guerra JL, Castilla-Cortazar I, Aguirre GA, et al. Partial IGF-1 deficiency is sufficient to reduce heart contractibility, angiotensin II sensibility, and alter gene expression of structural and functional cardiac proteins. PLoS One. 2017;12(8):e0181760. doi: 10.1371/journal.pone.0181760.
  15. Purkait P, Halder K, Thakur S, et al. Association of angiotensinogen gene SNPs and haplotypes with risk of hypertension in eastern Indian population. Clin Hypertens. 2017;23:12. doi: 10.1186/s40885-017-0069-x.
  16. Manna P, Jain SK. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metab Syndr Relat Disord. 2015;13(10):423–444. doi: 10.1089/met.2015.0095.
  17. Ito F, Sono Y, Ito T. Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: oxidative stress in diabetes, atherosclerosis, and chronic inflammation. Antioxidants (Basel). 2019;8(3). pii: E72. doi: 10.3390/antiox8030072.
  18. Yuan H, Wang X, Xia Q, et al. Angiotensin converting enzyme (I/D) gene polymorphism contributes to ischemic stroke risk in Caucasian individuals: a meta-analysis based on 22 case-control studies. Int J Neurosci. 2016;126(6):488–498. doi: 10.3109/00207454.2015.1036421.
  19. Mulerova T, Ogarkov M, Uchasova E, et al. A comparison of the genetic and clinical risk factors for arterial hypertension between indigenous and non-indigenous people of the Shoria Mountain Region. Clin Exp Hypertens. 2018;40(4):324–331. doi: 10.1080/10641963.2017.1377215.
  20. Malueka RG, Dwianingsih EK, Sutarni S, et al. The D allele of the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism is associated with worse functional outcome of ischaemic stroke. Int J Neurosci. 2018;128(8):697–704. doi: 10.1080/00207454.2017.1412962.
  21. Lambrinoudaki I, Chatzivasileiou P, Stergiotis S, et al. Subclinical atherosclerosis and vascular stiffness in premenopausal women: association with NOS3 and CYBA polymorphisms. Heart Vessels. 2018;33(12):1434–1444. doi: 10.1007/s00380-018-1198-1.
  22. Incalza MA, D’Oria R, Natalicchio A, et al. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol. 2018;100:1–19. doi: 10.1016/j.vph.2017.05.005.
  23. Huang MJ, Wei RB, Zhao J, et al. Albuminuria and endothelial dysfunction in patients with non-diabetic chronic kidney disease. Med Sci Monit. 2017;23:4447–4453. doi: 10.12659/msm.903660.
  24. Nawaz SK, Rani A, Yousaf M, et al. Genetic etiology of coronary artery disease considering NOS 3 gene variant rs1799983. Vascular. 2015;23(3):270–276. doi: 10.1177/1708538114544783.
  25. Cheng HM, Park S, Huang Q, et al.; Characteristics on the management of hypertension in Asia-Morning Hypertension Discussion Group (COME Asia MHDG). Vascular aging and hypertension: Implications for the clinical application of central blood pressure. Int J Cardiol. 2017;230:209–213. doi: 10.1016/j.ijcard.2016.12.170.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Akopyan A.A., Kirillova K.I., Strazhesko I.D., Samokhodskaya L.M., Leonov S.L., Gelfand E.M., Sorokina A.G., Orlova I.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies